<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-142824</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Impact of breast cancer screening on survival in the General Hospital of Segovia (Spain)</dc:title>
<dc:description xml:lang="en">Objectives: To analyze whether the program for breast cancer screening in the Spanish province of Segovia has increased the survival rate among the population with this disease. Secondary objective: to analyze the magnitude of this improvement at 5, 10 and 15 years of follow-up. Materials and methods: We performed a descriptive, retrospective study that analyzed the survival rates in 253 patients diagnosed with breast cancer by the breast cancer screening program (1992-2007), as well as survival in 312 patients, diagnosed in routine clinical practice. All patients were treated in the General Hospital of Segovia. Results: The survival rate in the screening group was clearly higher than that in the group diagnosed in routine clinical practice. This difference was more marked with increasing follow- up: 93% vs 78% at 5 years, 89% vs 68% at 10 years and 86% vs 56% at 15 years. Conclusions: Survival has improved since the start of the screening program. This increase was especially marked in the 15 years of follow-up, representing a difference of 30% (AU)</dc:description>
<dc:creator>Santamaría Lozano, Ricardo</dc:creator>
<dc:creator>Miranda Serrano, Pilar</dc:creator>
<dc:creator>Gómez Calvo, Ana Isabel</dc:creator>
<dc:creator>García López, Guadalupe</dc:creator>
<dc:creator>Verdú Martín, Luis Ignacio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos: Analizar si el programa de cribado del cáncer de mama en la provincia de Segovia ha supuesto una mejora en la supervivencia en la población afecta por este tumor. Objetivo secundario: analizar la magnitud de esta mejora a los 5, 10 y 15 años de seguimiento. Material y métodos: Estudio retrospectivo descriptivo, analiza la supervivencia de 253 pacientes diagnosticadas de cáncer de mama por el programa de cribado (desde 1992-2007) y la supervivencia de 312 diagnosticadas a través del marco asistencial habitual, todas ellas tratadas en el Hospital General de Segovia. Resultados: La supervivencia en el grupo de cribado es netamente superior a la del grupo de diagnóstico clínico, siendo la diferencia ma &amp;#769;s marcada a medida que aumenta el seguimiento: 93% vs 78% a los 5 años; 89% vs 68% a los 10 años; 86% vs 56% a los 15 años. Conclusiones: Se ha conseguido mejorar la supervivencia desde la puesta en marcha del programa de cribado, especialmente se observa a los 15 años de seguimiento, una diferencia del 30% (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);54(4): 157-161, abr. 2011. graf, tab</dc:source>
<dc:identifier>ibc-142824</dc:identifier>
<dc:title xml:lang="es">Impacto en la supervivencia del cribado del cáncer de mama en el Hospital General de Segovia</dc:title>
<dc:subject>^d25123^s22045</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d25123^s22002</dc:subject>
<dc:subject>^d52438</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28571</dc:subject>
<dc:subject>^d14190^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d14190^s22039</dc:subject>
<dc:subject>^d1968^s22061</dc:subject>
<dc:subject>^d13915^s22056</dc:subject>
<dc:subject>^d13915^s22031</dc:subject>
<dc:subject>^d1968^s22057</dc:subject>
<dc:subject>^d1968^s22067</dc:subject>
<dc:subject>^d1968^s22059</dc:subject>
<dc:type>article</dc:type>
<dc:date>201104</dc:date>
</metadata>
</record>
</ibecs-document>
